Supplemental Methods and Results from First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors

Autor:	David M. Goldenberg, Robert M. Sharkey, Steven A. Hamburger, William A. Wegener, Pius P. Maliakal, Serengulam V. Govindan, Sajeve S. Thomas, Linda T. Vahdat, Vincent J. Picozzi, Michael J. Guarino, Manish A. Shah, Allyson J. Ocean, Alexander N. Starodub
Rok vydání:	2023
DOI:	10.1158/1078-0432.22457150
Popis:	This file contains additional methods, including eligibility criteria, study design, pharmacokinetics and immunogenicity, and immunohistology, as well as additional results related to several notable patient narratives.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c35566f1635eeaa794737d1de0e61a4 https://doi.org/10.1158/1078-0432.22457150 Zobrazit plný text záznamu